Introduction
Malnutrition can be defined as 'a state of nutrition in which deficiency, excess or imbalance of energy, protein, and other nutrients causes measurable adverse effects on tissue and body form (body shape, size, composition), function and clinical outcome' (1, 2) . It is a serious and common condition associated with significant morbidity and mortality, affecting adults and children with all types of diseases in all healthcare settings. The prevention, identification and treatment of malnutrition at an early stage could reduce potential health risks, dependency on others, hospital admissions and costs (3, 4) . The economic impact of a risk of malnutrition as a result of an increased use of health and social care resources, hospitalisation and length of hospital stay, as identified using tools including 'MUST', is well documented (5, 6) . A study conducted in Portugal on 637 inpatients found that a high risk of malnutrition in 21-29% patients, as identified using malnutrition screening tools, was an independent predictor of increased hospitalisation costs (7) . The National Institute for Health and Care Excellence recommend that all outpatients should be screened for malnutrition at their first appointment and screening should be repeated when there is clinical concern (8) . Crohn's disease (CD) and ulcerative colitis (UC) are the main types of inflammatory bowel diseases (IBD), with a rarer type (unclassified IBD-U) accounting for approximately 10% of all cases (9) . In a northern English population, the prevalence of IBD has been estimated at approximately 387 per 100 000 population (243 per 100 000 with UC and 144 per 100 000 with CD) in 1995, with the prevalence of CD increasing faster than UC (10) . IBD is associated with substantial morbidity; one aspect includes nutritional status where malnutrition and weight loss are common (11, 12) . Up to 75% of adults with active IBD are malnourished (13) (14) (15) and up to 33% of adults in remission have been found to be malnourished ( 16 ) . IBD patients often alter their eating habits to alleviate their symptoms, potentially leading to malnutrition and weight loss (17) . In addition to protein-energy malnutrition, deficiencies in trace elements and vitamins such as magnesium, iron and vitamin B 12 are common (18, 19) . Prolonged symptoms, as well as disease management either by drug treatment or surgery, may further impact on the nutritional status of patients.
Food and nutrition is viewed as a high priority for IBD patients (20) and yet dietetic service provision remains poor, with approximately 60% of inpatients receiving no dietetic contact (21) . Malnutrition can be under-recognised in IBD patients because routine screening is not common practice, resulting in under-detection and thus under-treatment of malnutrition (22, 23) . Factors contributing to this include: a lack of recognition of the detrimental effects of malnutrition in IBD, difficulties implementing nutritional plans, a lack of staffing in busy outpatient clinics and a lack of guidance on the management of those identified at risk of malnutrition (21) . A systematic review looking at barriers and facilitators of adoption of nutritional screening by nurses concluded that it was unlikely, unless it was considered as an integral part of the nursing assessment and was appropriately resourced (24) . The use of patient self-administered malnutrition screening tools has been shown to be beneficial in the hospital outpatient setting (25) . The UK IBD Audit (21) advises that all IBD inpatients are screened for malnutrition and recommend 'MUST' as an appropriate tool. In addition, although nutritional screening guidelines exist for a variety of healthcare settings (26) , no specific screening tool has been developed for IBD outpatients. Patient-administered self-screening has recently been investigated in different studies and has demonstrated benefits in various disease states (1, 22, 25, 27) . The 'MUST' tool is considered an appropriate malnutrition screening tool because it has face, content, concurrent and predictive validity with a range of other screening tools. It is also internally consistent and reliable and has very good to excellent reproducibility when used with different assessors in a variety of settings. Guerra et al. (7) found agreement between 'MUST' and the ESPEN (European Society of Parenteral and Enteral Nutrition) recommended Nutrition Risk Screening tool (26) as a predictor for increased hospitalisation costs. The 'MUST' tool has been found to be easy, quick to use and acceptable to patients, research participants and healthcare workers (28, 29) . Previous research examining selfscreening in outpatients is either not IBD specific (1, 27, 28) or has not been conducted in the UK population (22) . The present study aimed to assess feasibility (completion time and ease of use) and validity of 'MUST'-P compared to risk classification obtained by healthcare professional administered 'MUST' ('MUST'-HCP) in IBD outpatients. This research has the potential to improve patient care by contributing to the identification of a risk of malnutrition, which has an impact not only on the disease related complications, but also on healthcare costs (30) . Nutritional support to treat malnutrition may improve symptoms and allow deficiencies in calories as well as macro-and micronutrients to be rectified (18) .
Materials and methods

Study design and population
The present study comprised a feasibility and validity study (31) . Eighty-three patients in the adult IBD outpatient clinic at University College London Hospital (UCLH) were approached from the waiting area using convenience sampling over an 8-week period between May 2015 and July 2015. The inclusion criteria were patients with a confirmed IBD diagnosis and who were aged ≥18 years. Exclusion criteria were unwillingness or inability to provide informed consent and an inability to communicate in the English language. Patients accompanied by a relative able to translate or act as an interpreter were recruited. Every effort was made to recruit all eligible patients to minimise selection bias. However, three patients declined the invitation to participate, making the sample size 80 patients.
Ethical approval was sought from London Metropolitan University Ethics Committee and by the UCLH research and development committee. Full ethical approval was not required because the study was deemed part of service evaluation. Written informed consent was obtained from all study participants and patients were assured of confidentiality and anonymity.
Data collection
The tools utilised for the data collection were the patientadministered screening tool ('MUST'-P) followed by the 'MUST' tool completed by the researcher ('MUST'-HCP) to screen the participants for malnutrition. Using routinely collected data from electronic databases and paper medical records, information was collected on the characteristics of the patient group, including demographics (date of birth, sex); anthropometry (height, weight and weight changes); and IBD type and date of diagnosis obtained from medical records. Well-being was taken from validated tools to measure disease activity in IBD: the Harvey Bradshaw Index (32) for CD and the Simple Clinical Colitis Activity Index (33) for UC, which measures wellbeing on a five-point likert scale from 'very well' (0) to 'terrible' (4) . Referral to a dietitian subsequent to diagnosis was also obtained. Area deprivation was based on national specific data of multiple deprivation rank from 2015, a composite score including income; employment; education, training and skills; health deprivation and disability; crime, barriers to housing and services; and living environment deprivation, with one missing value because one patient's postcode could not be assigned a deprivation score (34) . The research team consisted of two qualified dietitians.
Malnutrition tools
'MUST'-P Patients were provided with a simple instruction sheet, body mass index (BMI) chart and weight loss tables. The HCP recorded the length of time that the patient took to complete the tool. The patients were asked initially to complete the 'MUST'-P independently. The 'MUST'-P was the 'MUST' tool developed by Cawood et al. (27) who adapted 'MUST' for patient use in a hospital outpatient setting. The BMI and weight loss charts were used from the British Association for Parenteral and Enteral Nutrition (BAPEN) tool kit (35) . Following completion of the 'MUST'-P, the patient was asked to rate the ease-of-use of the 'MUST'-P tool on a Likert scale (very difficult to very easy) and time for completion (in minutes) was estimated by the patient.
'MUST'-HCP The screening was completed by a trained HCP researcher using the BAPEN resources (35) . Weighing scales and a stadiometer were both available in the clinic. Patients' height and weight was measured by a trained HCP and documented in the medical notes. The patients were informed of their weight and height.
Statistical analysis
Frequencies and percentages (%) were used to describe categorical variables. Mean, SD and range (minimum and maximum) were used to describe continuous variables. Area deprivation was categorised as 'least' and 'most' by using the median of the national index of multiple deprivation rank. Risk scores from both administrations of 'MUST' were classified as low (score = 0), medium (score = 1) and high (score ≥ 2) risk, from which sensitivity and specificity was calculated. Agreement between the two tools was assessed using kappa statistics. The kappa coefficient (j) was interpreted using the grading system of Landis and Koch (<0 = no agreement; 0-0.20 = slight; 0.21-0.40 = fair; 0.41-0.60 = moderate; 0.61-0.80 = substantial; 0.81-1 = almost perfect agreement) (36) . In sensitivity analyses, we examined whether patient characteristics; age (young versus old); sex (men versus women); and IBD duration (short versus long) would influence agreement between 'MUST'-P and 'MUST'-HCP.
Differences in demographic variables by IBD status (CD versus UC) are presented as the mean (SD) for normal continuous data and n (%) for categorical data, and were tested using t-tests and chi-squared tests, respectively. P < 0.05 (two-tailed) was considered statistically significant. Statistical analysis was conducted using STATA, version 14 (StataCorp, College Station, TX, USA). Table 1 shows the demographic and clinical characteristics of the 80 IBD patients who participated in the present study. Overall, the study sample consisted of 51.2% males and the mean (SD) age of participants was 39.9 (15.1) years (range 19-84 years). The majority of the participants n = 49 (61.3%) had CD. No demographic or clinical characteristics were significantly different by IBD status except area deprivation, where those with CD were least likely to live in a deprived area compared to UC patients (P = 0.01). However, there was a nonsignificant trend towards a lower BMI in the CD versus UC group. In total, one UC patient had active disease and three CD patients had active disease (two mild and one moderate).
Results
Study population
Agreement between 'MUST'-P and 'MUST'-HCP screening
Of the eighty IBD patients included in the study, three patients (3.8%) refused to complete the 'MUST'-P for the following reasons: one because of eye sight difficulties, one considered that it should be conducted by a HCP and one did not state a reason. Thus, the total sample size included for agreement analysis of 'MUST'-P and 'MUST'-HCP is n = 77.
There was 100% sensitivity for patients who were at medium or high risk using the 'MUST'-P tool compared to the 'MUST'-HCP tool. However, specificity was somewhat lower in that two were scored as medium risk and 15 patients scored as high risk using 'MUST-P', whereas they were scored as low risk using 'MUST'-HCP. Overall, this meant that there was moderate agreement between the 'MUST'-P and 'MUST'-HCP scores as determined by the kappa statistic (j = 0.486, P < 0.001). We found no evidence that agreement between 'MUST'-P and 'MUST'-HCP was affected by stratification by age, sex or IBD duration.
Ease of use and time to complete 'MUST'-P Overall, 51.9% (n = 40) of patients' reported the completion of 'MUST'-P as easy, with 40.2% (n = 31) rating it as very easy, 6.5% (n = 5) as difficult and 1.3% (n = 1) as very difficult. The mean (SD) time for the completion of the questionnaire was 3.1 (1.8) min (range 1-10 min).
Prevalence of malnutrition assessed by 'MUST'-P
A comparison of the risks of malnutrition as identified by the patients themselves and the researcher is shown in Table 2 . There was 100% agreement between 'MUST-P and 'MUST'-HCP for all patients with medium and high risk of malnutrition. However, this reduced to 74.3% agreement with the 'MUST'-HCP score in the low-risk Data are presented as the mean (SD), n (%), using an unpaired t-test and a chi-squared test to test for differences by IBD group. P-values represent differences between subgroups ulcerative colitis (UC) and Crohn's disease (CD) only. *Including Crohn's colitis. † Well-being variable was categorised as very well (score 0) versus all other scores (1-4) when compared by IBD group using the chi-squared test. ‡ Area deprivation variable includes n = 1 missing value. BMI, body mass index; IBD, inflammatory bowel disease.
category. This was a result of 17 discrepancies with lowrisk categories, mostly associated with difficulty reading the BMI chart 22.7% (n = 15) and 3% (n = 2) were related to the weight loss score. The proportion of participants with medium-and high-risk scores of malnutrition was explored using the 'MUST'-HCP. The results show similar proportions of the sample in the medium-and high-risk malnutrition categories: 8.8% (n = 7 patients) at medium risk and 6.3% (n = 5 patients) at high risk of malnutrition when screened by the researcher. Of the patients in the study at high risk of malnutrition, two out of five had not been referred to a dietitian subsequent to diagnosis and one out of five had seen a dietitian but did not arrange a follow-up. In total, 50 patients (62.5%) had seen a dietitian subsequent to diagnosis. The majority of patients (91.3%) had a BMI score 0 in the initial part of the 'MUST'. Seventy-one patients (88.8%) had minimal weight loss (≤5%) in the past 6 months and all the patients (100%) were not acutely ill when completing the study.
Outcomes of the three steps of 'MUST' used by the researcher to identify malnutrition
For the 80 patients screened, the 'MUST'-HCP identified that 85% (n = 68) 8.8% (n = 7) and 6.3% (n = 5) had a low, medium and high risk of malnutrition, respectively. Some 91.3% (n = 73) of patients had a low-risk BMI, 3.8% (n = 3) had a medium-risk BMI and 5% (n = 4) had a high-risk BMI. In addition, 85% (n = 68) of patients had no weight loss. Of the 15% with weight loss, 88.8% (n = 71) had <5%, 8.8% (n = 7) had 5-10% and 2.5% (n = 2) had >10% weight loss. None of the patients were considered acutely unwell. One patient at medium risk and one patient at high risk using 'MUST'-HCP had moderately active disease.
Discussion
Overall, the results of the present study showed that 'MUST'-P can be used to capture medium and high risks of malnutrition in the IBD outpatient setting. If accurately implemented, this could be included in patients' nutritional assessments. This bridges a gap in knowledge because there is limited research to date exploring use of self-screening in IBD outpatients, particularly from UK-based studies.
Accuracy of tool and ease of use of 'MUST'-P
Patient self-screening has been found to be an easy and well accepted tool, generating precise measurements compared to those made by a HCP (25) . The present study found a moderate agreement between 'MUST'-P and 'MUST'-HCP (j = 0.486, P < 0.001), such that 100% of IBD patients with medium and high risk of malnutrition were identified by the patient and the HCP, providing confidence in using a patient-administered tool.
However, 17 'MUST'-P related discrepancies were identified, mainly relating to difficulty reading the BMI chart. In addition, there was no influence of age, sex and IBD duration on agreement between 'MUST'-P and 'MUST'-HCP. Other studies have found the discrepancies between HCP and patient self-screening were mostly associated with the weight loss and BMI score (22, 27) . The use of mobile technology for calculating 'MUST' scores could help facilitate the implementation of 'MUST'-P by improving its accuracy and ease of use for patients, thus improving compliance. McGurk et al. (25) investigated 'MUST' self-screening using digital technology to calculate BMI in a gastroenterology outpatient clinic. All patients were able to self-screen and there was perfect agreement in test-retest reliability between the patient and dietitian, suggesting that use of digital screening may produce more accurate results.
Based on previous published studies, with the exception of reports from McCurk et al. (25) , the majority of IBD patients reported the completion of 'MUST'-P as being either easy or very easy. The present study is consistent with previous findings by Sandhu et al. (22) where 96% of IBD patients rated self 'MUST' screening as being either easy or very easy to understand and complete. The present study used a patient friendly version of 'MUST' adapted from Cawood et al. (27) . In our study, the mean (SD) time for completion was 3.1 (1.8) min (range 1-10 min) and 100% completed the tool in 5 min or less. Cawood et al. (27) found that 75% of 205 outpatients were able to screen themselves in less than 5 min and rated the self-screening as easy or very easy. In a Canadian study (22) of 154 IBD adult outpatients, all patients were able to self-screen and 96% reported the tool as being either easy or very easy to use. Cawood et al. (27) observed that the overall prevalence of malnutrition (medium and high risk) was similar between selfscreening (19.6%) and HCP screening (18.6%), which correlated well with our study findings.
Prevalence of malnutrition
The present study suggests that the prevalence of malnutrition in the IBD outpatient setting at UCLH is low compared to other published studies (13) (14) (15) (16) . This is possibly enhanced via the close monitoring by an IBD multidisciplinary team. However, because of the small size in the present study, these results should be viewed with caution. When screened by the HCP, the majority of patients (85%) were at low risk of malnutrition, with 8.8% and 6.3% of the sample being at medium and high risk, respectively. Seventy-one patients reported less than 5% of weight loss in the last 6 months and had a low-risk BMI.
Few studies to date have specifically looked at prevalence of malnutrition in IBD outpatients. Vadan et al. (15) found that 59.3% of 30 patients attending a gastroenterology clinic in Bucharest were malnourished, whereas, in a UK-based study (29) , there was a high prevalence of malnutrition identified in general gastroenterology outpatients using different tools including 'MUST'. Interestingly, in the present study, the mean BMI score indicated the UC patients were overweight (mean BMI = 27.6 kg m -2 ) and CD patients were at the upper end of the healthy weight range (mean BMI = 25.3 kg m -2 ). Obesity and increased fat mass are both associated with elevated inflammatory markers and a more severe disease course in CD patients (37, 38) . Although 'MUST' is able to detect higher proportions of a risk of malnutrition compared to BMI alone, basic anthropometry is insufficient to differentiate fat mass and lean body mass. In a prospective controlled study among IBD patients, despite 74% of IBD patients having a normal BMI, handgrip strength and lean body mass was impaired in both CD and UC patients (12) . More than half of IBD patients were found to have muscle mass depletion despite a normal BMI (39) because IBD not only causes weight change, but also alters body composition. Assessment of body composition in addition to simple anthropometry would better indicate nutritional status in IBD patients.
Specific micronutrient deficits, loss of body cell mass and muscle strength often persist even in disease remission and would not be detected by standard malnutrition screening alone (12) . In the IBD cohort, it may not be possible to fully evaluate a risk of malnutrition based solely on malnutrition screening as a result of the complex nature of the disease.
Bioelectrical impedance analysis (BIA) is a measure of body composition that can be used to differentiate between fat and fat free mass and is also a predictor for nutritional status (39) . BIA is used in clinical settings because it is considered to be non-invasive, no technical skill is required and it is comfortable for patients compared to other methods. However, BIA is expensive and time consuming and, as a result of time and staffing constraints in a busy outpatient setting, a more economic and practical measurement of body composition is required.
Tricep skinfold thickness (TSF) is the most frequently used method for assessment of body composition because it is cheap and feasible. Body fat can be predicted by the sum of skinfold thickness from different parts because the total body fat correlates with subcutaneous fat (40) . TSF has been found to correlate well with BIA in a study that evaluated the body fat estimated by BIA and TSF on 348 undergraduate students and it was concluded that the anthropometric method can surrogate fat mass percentage and assess body fat when BIA is unavailable (41) . The addition of TSF may be useful to support 'MUST' in identifying a risk of malnutrition in the IBD patient cohort. However, the acceptability of this additional measure in the IBD patient group would require further testing in clinical practice.
Implications
Implementing 'MUST'-P could potentially reduce the workload demands on HCPs to screen patients for the identification of a risk of malnutrition with respect to patients in the outpatient setting. Furthermore, the use of self-screening has the capacity to promote patient involvement in their own care. However, as a result of the complex nature of IBD, there are concerns that using a generic malnutrition screening tool may not capture all patients at risk of malnutrition. It may be that screening in the community is a more appropriate setting for 'MUST' where rates of under-recognised and under-treated malnutrition are known to be high (35) . Patients could be advised to use the web-based malnutrition self-screening tool based on 'MUST developed and available on the BAPEN website (35) , which is designed to help adults to identify their own risk of malnutrition in the community.
Recommendations for further research
To be able to generalise these findings to the wider IBD population, larger studies are required in different UK hospital outpatient settings.
The use of HCP led focus groups could be used to explore perceptions of 'MUST'-P and help to identify the potential barriers and facilitators of its use develop the tool further and improve its accuracy and validity. To enable successful implementation of 'MUST'-P in the outpatient setting, appropriate and practical malnutrition care pathways would need to be developed so that those identified as malnourished are appropriately managed and treated. However, dietetic resourcing available for those patients identified at high risk may be a limiting factor.
Limitations
Test-retest reliability was performed both by Cawood et al. (27) and McCurk et al. (25) aiming to compare the accuracy of two different self-screening scores. Similar to the work of Sandhu et al. (22) , the present study did not perform testretest reliability because there would be a short duration of time between baseline 'MUST'-P and repeat screening and it is highly likely the patients would recall their baseline score, potentially introducing reporting bias. Only three patients approached refused to complete 'MUST'-P, indicating a high response rate. The sample size of 80 compares favourably to other studies in IBD cohorts (20) . A limitation of the validity of the study was, that because of the low numbers of patients with active disease, it was not possible to assess whether there was a significant relationship between disease activity and 'MUST' score. The results of the present study correlate well with a previous larger study in a similar patient cohort (22) . However, the results of our study cannot be generalised to the wider population because of the small sample size, which was restricted to a single UK-based large tertiary hospital.
Conclusions
The findings of the present study confirm previous findings suggesting that 'MUST'-P is a quick and easy method of nutritional screening for use in a busy outpatient setting. Moderate agreement was found between 'MUST'-HCP and 'MUST'-P, with the strongest agreement for medium-and high-risk patients. Although the overall malnutrition rates were found to be low, not all patients recognised as being at high risk of malnutrition by 'MUST'-HCP were referred to the dietitian. Furthermore, as a result of the complexity of nutritional issues specific to IBD patients, the use of a generic tool may risk missing patients considered as low risk that may still require nutritional intervention. To ensure all nutritionally at risk patients are identified, it is recommended that this tool is combined with measurement of body composition and consideration of micronutrient serum levels. Frequent and regular nutritional screening in all healthcare settings will allow a risk of malnutrition to be identified early and be prevented or treated appropriately.
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